Literature DB >> 18507081

Evaluation and comparison of the clinical, surgical and pathological TNM staging of colorectal cancer.

Revekka Harisi1, Zsuzsanna Schaff, Lajos Flautner, Tamas Winternitz, Balazs Jaray, Zsuzsanna Nemeth, Peter Kupcsulik, Janos Weltner.   

Abstract

BACKGROUND/AIMS: The aim of our study was to compare the results of clinical, surgical and pathological staging of colorectal cancer.
METHODOLOGY: 660 patients with colorectal carcinoma were included in the study. The results of the clinical, surgical and pathological staging were compared.
RESULTS: Clinical T values were identical with the surgical in 75.15%, and with the pathological in 74.54% respectively. Surgical T values were identical with the clinical in 78.48%. In 67.27% of the cases the clinical evaluation of N value was identical with the surgical one. Clinical evaluation was identical with the pathological result in 60.60% of the cases. Surgical diagnosis of the lymph node metastasis matched the pathological finding in 76.66%. Regarding the M value, the coincidence of the diagnoses was as follows: clinical versus pathological 72.72%, surgical versus pathological 90.90%. Clinical and surgical TNM stages were by 79.09% in accordance. By decision of total TNM stage the clinical-pathological staging showed worse (76.06%), while surgical-pathological showed significantly better (88.48%) matching.
CONCLUSIONS: Based on our results we can state that in a quarter of all colorectal cancer cases the extent of the primary tumor could not have been established correctly. The lymph node involvement was well defined in just over half of the cases only. The M values were accurately stated in about three quarters of the cases. High grade of conformity of clinical, surgical and pathological staging can result in better treatment-planning, short- and long-term survival, and higher quality of life.

Entities:  

Mesh:

Year:  2008        PMID: 18507081

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

1.  Macroscopic serosal invasion and small tumor size as independent prognostic factors in stage IIA colon cancer.

Authors:  Soo Young Lee; Chang Hyun Kim; Young Jin Kim; Hyeong Rok Kim
Journal:  Int J Colorectal Dis       Date:  2018-04-28       Impact factor: 2.571

2.  Prognostic value of lymph node ratio in resectable rectal cancer after preoperative short-course radiotherapy-results from randomized clinical trial.

Authors:  Radoslaw Pach; Antoni M Szczepanik; Marek Sierzega; Michal Daniluk; Piotr Richter
Journal:  Langenbecks Arch Surg       Date:  2022-07-04       Impact factor: 3.445

3.  The value of lymph node ratio in the prediction of rectal cancer patient survival after preoperative chemoradiotherapy.

Authors:  Li Chen; Xuefeng Huang; Zhangfa Song
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

4.  Improvement of T stage precision by integration of surgical and pathological staging in radically resected stage pT3-pT4b gastric cancer.

Authors:  Hong-Hu Wang; Kai Li; Hao Xu; Zhe Sun; Zhen-Ning Wang; Hui-Mian Xu
Journal:  Oncotarget       Date:  2017-07-11

5.  Comparison of Long-Term Oncologic Outcomes Between Surgical T4 and T3 in Patients Diagnosed With Pathologic Stage IIA Right Colon Cancer.

Authors:  Youngbae Jeon; Kug Hyun Nam; Seok Won Choi; Tae Sik Hwang; Jeong-Heum Baek
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

6.  The integration of macroscopic tumor invasion of adjacent organs into TNM staging system for colorectal cancer.

Authors:  Ji-Wang Liang; Peng Gao; Zhen-Ning Wang; Yong-Xi Song; Ying-Ying Xu; Mei-Xian Wang; Yu-Lan Dong; Hui-Mian Xu
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

7.  Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.

Authors:  Zhi-Gui Zuo; Xiu-Feng Zhang; Hao Wang; Qi-Zhi Liu; Xing-Zhao Ye; Chang Xu; Xiang-Bin Wu; Jian-Hui Cai; Zhen-Hua Zhou; Jin-Lei Li; Hua-Yu Song; Zu-Qiang Luo; Peng Li; Shi-Chang Ni; Lei Jiang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.